Further research and development on erythrocyte glutathione efflux inhibitors may provide novel therapeutic interventions for alleviation of oxidative stress-associated clinical abnormalities in beta thalassemia/Hb E patients such as anemia and iron overload. The gene discussed is GSTM1; the disease is beta thalassemia.